HomeCasesEli Lilly
AI business transformation · Pharmaceuticals

Eli Lilly

Delivered AI Foundation for Eli Lilly. Quantitative effect metrics have not been collected, and we do not infer them here.

AI FoundationScope delivered

Client

Eli Lilly is a multinational pharmaceutical company, and a client of the AI business transformation line — the relevant services being AI advisory and selection, and agent delivery.

The problem

For large pharmaceutical companies the bottleneck in AI adoption is rarely the model; it is the foundations. Data sits in separate business systems, compliance requirements are strict, and departments running independent pilots duplicate each other. A reusable base layer has to exist before individual applications are worth rolling out.

What we did

Delivered AI Foundation, a base capability layer for enterprise AI.

Limits of this case

  • Foundation projects do not produce business metrics directly. Their value shows up in the build speed and reuse rate of the applications that follow, so judging them on short-term ROI produces misleading conclusions.
  • Pharmaceutical compliance constraints — data privacy, content review, traceability — are considerably tighter than in most industries, and the design does not transfer directly to other sectors.

Service behind it

AI advisory and technology selection · All client cases

Want the same measurement on your brand?Start with the free GEO audit: one domain in, a current-state report out.
Free GEO audit
Moments — AI growth and business transformation, built and delivered from Shanghai.Email contact@moments.top · ICP filing 沪ICP备2025143616号

This page in Chinese: 中文版案例